BIOVIE INC(NASDAQ:BIVI) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to BIVI. BIVI was compared to 567 industry peers in the Biotechnology industry. No worries on liquidiy or solvency for BIVI as it has an excellent financial health rating, but there are worries on the profitability. BIVI does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year BIVI has reported negative net income.

BIVI had a negative operating cash flow in the past year.

In the past 5 years BIVI always reported negative net income.

BIVI had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

BIVI's Return On Assets of -99.36% is on the low side compared to the rest of the industry. BIVI is outperformed by 76.15% of its industry peers.

With a Return On Equity value of -106.72%, BIVI perfoms like the industry average, outperforming 43.64% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-99.36%
ROE	-106.72%
ROIC	N/A

ROA(3y)-1103.91%

ROA(5y)-1006.53%

ROE(3y)-1559.62%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

BIVI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The number of shares outstanding for BIVI has been reduced compared to 1 year ago.

BIVI has more shares outstanding than it did 5 years ago.

Compared to 1 year ago, BIVI has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -15.45, we must say that BIVI is in the distress zone and has some risk of bankruptcy.

With a Altman-Z score value of -15.45, BIVI is not doing good in the industry: 81.27% of the companies in the same industry are doing better.

BIVI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-15.45

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 16.94 indicates that BIVI has no problem at all paying its short term obligations.

The Current ratio of BIVI (16.94) is better than 92.76% of its industry peers.

BIVI has a Quick Ratio of 16.94. This indicates that BIVI is financially healthy and has no problem in meeting its short term obligations.

BIVI's Quick ratio of 16.94 is amongst the best of the industry. BIVI outperforms 92.76% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	16.94
Quick Ratio	16.94

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

BIVI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -24.94%.

EPS 1Y (TTM)-24.94%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%79.09%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, BIVI will show a very strong growth in Earnings Per Share. The EPS will grow by 23.11% on average per year.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y22.85%

EPS Next 2Y30.83%

EPS Next 3Y25.16%

EPS Next 5Y23.11%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BIVI. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BIVI. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

BIVI's earnings are expected to grow with 25.16% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y30.83%

EPS Next 3Y25.16%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for BIVI!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

BIOVIE INC

NASDAQ:BIVI (5/2/2025, 8:00:01 PM)

After market: 1.34 +0.13 (+10.74%)

1.21

+0.35 (+40.37%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)02-11 2025-02-11/amc

Earnings (Next)05-12 2025-05-12/bmo

Inst Owners5.15%

Inst Owner Change-4.08%

Ins Owners0.9%

Ins Owner Change0%

Market Cap22.32M

Analysts82.5

Price Target5.61 (363.64%)

Short Float %7.12%

Short Ratio4.81

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)10%

PT rev (3m)10%

EPS NQ rev (1m)0%

EPS NQ rev (3m)0%

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	N/A
P/FCF	N/A
P/OCF	N/A
P/B	0.93
P/tB	0.96
EV/EBITDA	N/A

EPS(TTM)-15.6

EYN/A

EPS(NY)-4.5

Fwd EYN/A

FCF(TTM)-1.19

FCFYN/A

OCF(TTM)-1.19

OCFYN/A

SpS0

BVpS1.3

TBVpS1.26

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-99.36%
ROE	-106.72%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-1103.91%

ROA(5y)-1006.53%

ROE(3y)-1559.62%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score6

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	16.94
Quick Ratio	16.94
Altman-Z	-15.45

F-Score6

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-24.94%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%79.09%

EPS Next Y22.85%

EPS Next 2Y30.83%

EPS Next 3Y25.16%

EPS Next 5Y23.11%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y46.09%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-44.03%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-44.03%

OCF growth 3YN/A

OCF growth 5YN/A

BIOVIE INC (BIVI) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens